Xander Dobreff

National Sales Executive

Professional Overview
Xander Dobreff is an accomplished national sales executive with a proven track record of driving growth and success in the pharmaceutical industry. With over a decade of experience, he has developed a robust skill set in strategic account management, business development, and cross-functional collaboration.

Experience Summary

Current Role
As the National Sales Executive at Capital Wholesale Drug Company (Capital Drug), Xander is responsible for leading the company's national sales initiatives. In this role, he has implemented innovative sales strategies that have resulted in significant revenue increases and strengthened client relationships. Xander's deep understanding of the pharmaceutical landscape and his ability to identify and capitalize on market trends have made him a valuable asset to the organization.

Career Progression
Prior to his current role, Xander served as a Senior Account Executive at Auburn Pharmaceutical, where he consistently exceeded sales targets and cultivated strong partnerships with key clients. Additionally, he has been an active member of the SOCIETY OF HICKORY GOLFERS, where he has contributed his expertise and leadership as a board member.

Xander's entrepreneurial spirit is further demonstrated through his ownership of Dobreff Consulting, where he provides strategic advisory services to clients in the healthcare industry. His diverse experience and multi-faceted expertise have positioned him as a respected authority in the field.

Academic Background
Xander holds a Bachelor's degree in Business Administration from the University of Florida, where he graduated with distinction.

Areas of Expertise

• Strategic account management

• Business development and sales

• Pharmaceutical industry knowledge

• Cross-functional collaboration

• Entrepreneurial mindset

• Leadership and board experience

Professional Impact
Throughout his career, Xander has played a pivotal role in driving the success of the organizations he has been a part of. His contributions have been recognized through his appointment to the board of the NORTH AMERICAN ONE-ARMED GOLFER ASSOCIATION, where he has leveraged his expertise to advance the organization's initiatives.

Conclusion
Xander Dobreff's comprehensive industry knowledge, strategic acumen, and proven track record of success make him a valuable asset to any organization. As he continues to excel in his current role and explore new entrepreneurial opportunities, Xander is poised to make a lasting impact on the pharmaceutical industry and beyond.